According to the latest report by IMARC Group, titled "Global Gene Therapy Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027", The global gene therapy market reached a value of US$ 3.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.5 Billion by 2027 exhibiting a CAGR of 15.60% during 2022-2027.
|
Report
Metric |
|
Historical:
2016-2021 |
|
Base Year:
2021 |
|
Forecast
Year: 2022-2027 |
Gene Therapy Market Trends and Drivers:
The global gene therapy market is primarily driven by the growing incidences of inherited and acquired diseases, such as cancer, diabetes, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS).
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/gene-therapy-market/requestsample
Additionally,
the rising government support and funding for gene therapy research is another
major growth-inducing factor. Furthermore, the leading players are developing
advanced gene therapy products that offer a safer and non-addictive alternative
to opioids in treating numerous chronic pain conditions like lower back pain,
which is catalyzing the market growth.
Other
factors, including the aging population, increasing approvals of new gene
therapy technologies, easy access to healthcare facilities, and technological
advancements, are also anticipated to drive the market further.
Note: We are
regularly tracking the direct effect of COVID-19 on the market, along with the
indirect influence of associated industries. These observations will be
integrated into the report.
Global Gene
Therapy Market 2022-2027 Analysis and Segmentation:
Competitive
Landscape:
The
competitive landscape of the market has been studied in the report with the
detailed profiles of the key players operating in the market.
Abeona
Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc.,
Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bluebird Bio Inc., Mustang Bio
Inc. (Fortress Biotech Inc.), Novartis AG, Orchard Therapeutics plc, UniQure
N.V. and Voyager Therapeutics Inc.
The report has segmented the market on the basis of region, gene type, vector
type, delivery method and application
Breakup
by Gene Type:
· Antigen
· Cytokine
· Tumor
Suppressor
· Suicide
Gene
· Deficiency
· Growth
Factors
· Receptors
· Others
Breakup by Vector
Type:
· Viral
Vector
o
Adenoviruses
o
Lentiviruses
o
Retroviruses
o
Adeno-Associated Virus
o
Herpes Simplex Virus
o
Poxvirus
o
Vaccinia Virus
o
Others
· Non-Viral
Techniques
o
Naked and Plasmid Vectors
o
Gene Gun
o
Electroporation
o
Lipofection
o
Others
Breakup by Delivery
Method:
· In-Vivo
Gene Therapy
· Ex-Vivo
Gene Therapy
Breakup by Application:
· Oncological
Disorders
· Rare
Diseases
· Cardiovascular
Diseases
· Neurological
Disorders
· Infectious
Disease
· Others
Breakup by Region:
Ask Analyst
for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/gene-therapy-market
If you want
latest primary and secondary data (2022-2027) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours of receiving full payment.
Key
highlights of the report:
If you need
specific information that is not currently within the scope of the report, we
can provide it to you as a part of the customization.
About Us:
IMARC Group
is a leading market research company that offers management strategy and market
research worldwide. We partner with clients in all sectors and regions to
identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800